
Probiotec Limited
ASX:PBP.AX
2.98 (AUD) • At close June 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 214.028 | 182.328 | 120.507 | 107.22 | 73.237 | 75.725 | 62.546 | 65.607 | 65.68 | 68.215 | 67.343 | 66.046 | 71.77 | 79.101 | 87.147 | 66.139 | 53.992 | 0 |
Cost of Revenue
| 152.423 | 127.522 | 88.016 | 76.607 | 50.561 | 46.934 | 38.989 | 41.631 | 42.343 | 43.412 | 38.168 | 36.792 | 37.841 | 36.067 | 42.856 | 37.731 | 33.814 | 0 |
Gross Profit
| 61.605 | 54.805 | 32.491 | 30.613 | 22.675 | 28.791 | 23.557 | 23.976 | 23.337 | 24.803 | 29.175 | 29.255 | 33.93 | 43.034 | 44.291 | 28.408 | 20.178 | 0 |
Gross Profit Ratio
| 0.288 | 0.301 | 0.27 | 0.286 | 0.31 | 0.38 | 0.377 | 0.365 | 0.355 | 0.364 | 0.433 | 0.443 | 0.473 | 0.544 | 0.508 | 0.43 | 0.374 | 0 |
Reseach & Development Expenses
| 0.513 | 0.318 | 0.338 | 0.303 | 0.312 | 0.721 | 0.74 | 0.6 | 1.593 | 3.187 | 2.127 | 2.184 | 3.495 | 4.163 | 3.63 | 3.238 | 2.242 | 0 |
General & Administrative Expenses
| 29.847 | 26.24 | 19.489 | 12.991 | 9.863 | 0.656 | 0.487 | 0.446 | 0.447 | 0.486 | 0.607 | 0.92 | 0.932 | 0.652 | 0.644 | 2.818 | 2.499 | 0 |
Selling & Marketing Expenses
| 13.758 | 11.451 | 8.187 | 7.963 | 6.788 | 9.864 | 11.024 | 11.341 | 12.151 | 13.256 | 16.695 | 18.917 | 20.714 | 20.977 | 21.586 | 11.3 | 6.341 | 0 |
SG&A
| 40.874 | 35.174 | 25.011 | 18.616 | 16.651 | 10.52 | 11.512 | 11.787 | 12.598 | 13.742 | 17.301 | 19.837 | 21.646 | 21.629 | 22.23 | 14.118 | 8.84 | 0 |
Other Expenses
| 0.617 | 2.772 | 0.062 | 0.36 | 0.35 | 0.716 | 0.155 | 0.183 | 0.159 | 4.596 | 0.891 | 3.586 | 0.493 | 1.432 | 0.03 | 0.006 | 0.329 | 0 |
Operating Expenses
| 40.874 | 35.174 | 25.011 | 18.616 | 16.301 | 26.097 | 22.513 | 23.254 | 27.216 | 29.102 | 30.494 | 32.533 | 34.769 | 35.649 | 33.095 | 20.177 | 14.477 | 0 |
Operating Income
| 20.731 | 19.632 | 7.48 | 11.997 | 6.025 | 2.694 | 1.045 | 0.723 | -3.88 | -5.052 | -1.319 | -3.278 | -0.84 | 3.265 | 11.196 | 8.231 | 5.701 | 0 |
Operating Income Ratio
| 0.097 | 0.108 | 0.062 | 0.112 | 0.082 | 0.036 | 0.017 | 0.011 | -0.059 | -0.074 | -0.02 | -0.05 | -0.012 | 0.041 | 0.128 | 0.124 | 0.106 | 0 |
Total Other Income Expenses Net
| -5.157 | -1.514 | -3.301 | -1.93 | -1.504 | 1.79 | -0.779 | -0.494 | -1.498 | 3.143 | -0.697 | 5.516 | -0.897 | 6.857 | 0.855 | 0.27 | 0.361 | 0 |
Income Before Tax
| 15.574 | 18.036 | 7.719 | 8.897 | 4.521 | 5.746 | 3.546 | 3.088 | -5.378 | 0.749 | 1.544 | 2.238 | -1.737 | 10.122 | 12.05 | 8.501 | 6.061 | 0 |
Income Before Tax Ratio
| 0.073 | 0.099 | 0.064 | 0.083 | 0.062 | 0.076 | 0.057 | 0.047 | -0.082 | 0.011 | 0.023 | 0.034 | -0.024 | 0.128 | 0.138 | 0.129 | 0.112 | 0 |
Income Tax Expense
| 4.556 | 4.329 | 2.65 | 2.455 | 0.781 | 1.47 | 1.036 | 0.749 | -0.608 | -0.198 | 0.072 | 0.008 | 0.346 | 0.641 | 3.15 | 2.192 | 1.084 | 0 |
Net Income
| 11.018 | 13.707 | 4.846 | 3.506 | 3.74 | 3.577 | 2.264 | 4.013 | -24.742 | 0.904 | 0.597 | 1.249 | -10.338 | 9.481 | 8.901 | 6.309 | 4.978 | 0 |
Net Income Ratio
| 0.051 | 0.075 | 0.04 | 0.033 | 0.051 | 0.047 | 0.036 | 0.061 | -0.377 | 0.013 | 0.009 | 0.019 | -0.144 | 0.12 | 0.102 | 0.095 | 0.092 | 0 |
EPS
| 0.14 | 0.17 | 0.063 | 0.05 | 0.06 | 0.057 | 0.043 | 0.076 | -0.47 | 0.017 | 0.011 | 0.024 | -0.2 | 0.18 | 0.19 | 0.14 | 0.11 | 0 |
EPS Diluted
| 0.13 | 0.17 | 0.061 | 0.05 | 0.058 | 0.057 | 0.043 | 0.076 | -0.47 | 0.017 | 0.011 | 0.024 | -0.2 | 0.18 | 0.18 | 0.13 | 0.11 | 0 |
EBITDA
| 34.774 | 31.965 | 15.653 | 16.498 | 10.141 | 6.93 | 6.776 | 6.624 | 4.981 | 8.492 | 6.704 | 8.075 | 7.547 | 14.928 | 16.967 | 12.791 | 9.769 | 0 |
EBITDA Ratio
| 0.162 | 0.175 | 0.13 | 0.161 | 0.113 | 0.124 | 0.108 | 0.101 | 0.076 | 0.136 | 0.1 | 0.122 | 0.105 | 0.189 | 0.195 | 0.193 | 0.181 | 0 |